We are now evaluating BChE delivery by viral gene transfer in mouse models as a way to modulate ghrelin signaling, hoping that such an approach to restore health and resilience might aid patients with emotional disorders or clinical obesity. The gene discussed is GHRL; the disease is obesity disorder.